🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Maxigen Biotech Inc. (TPE:1783)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
31.80
-2.00 (-5.92%)
Nov 20, 2026, 1:30 PM CST

Maxigen Biotech Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
513.49576.19639.05431.08790.95513.31
Short-Term Investments
251.5300--8.8213.84
Cash & Short-Term Investments
764.99876.19639.05431.08799.76527.15
Cash Growth
4.63%37.11%48.24%-46.10%51.72%151.31%
Accounts Receivable
116.7132.19103.9188.3198.86109.95
Other Receivables
0.83--8.751.424.76
Receivables
117.54132.19103.9197.06100.27114.71
Inventory
91.5699.1975.7685.3275.4180.63
Prepaid Expenses
16.8211.979.824.5215.4147.78
Other Current Assets
3.461.931.791.582.3913.29
Total Current Assets
994.361,121830.33619.56993.25783.55
Property, Plant & Equipment
446.01442.83430.36424.18434.62465.45
Long-Term Investments
269.55279.68311.31432.8--
Other Intangible Assets
0.480.730.130.491.161.83
Long-Term Deferred Tax Assets
1.621.132.555.833.190.38
Other Long-Term Assets
52.3947.317.8110.1315.513.97
Total Assets
1,7641,8931,5821,4931,4481,265

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
64.7788.2249.9817.1735.9440.15
Accrued Expenses
-83.1172.0764.6355.3540.35
Short-Term Debt
-100----
Current Portion of Leases
-----2.36
Current Income Taxes Payable
-29.6125.5224.4727.179.28
Current Unearned Revenue
10.5615.122.931.344.2511.13
Other Current Liabilities
121.9833.0735.3723.7828.7912.8
Total Current Liabilities
197.31349.11205.87131.37151.5116.07
Long-Term Leases
-----7.28
Long-Term Deferred Tax Liabilities
0.711.180.930.490.55-
Other Long-Term Liabilities
2.945.260.560.020.020.12
Total Liabilities
200.95355.54207.36131.88152.07123.47

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
896.98896.8891.63889.34846.99769.99
Additional Paid-In Capital
331.71331.29326.93296.1281.9264.39
Retained Earnings
574.35534.5344.12244.46169.8110.3
Comprehensive Income & Other
-239.59-225-187.56-68.79-3.04-2.96
Total Common Equity
1,5631,5381,3751,3611,2961,142
Shareholders' Equity
1,5631,5381,3751,3611,2961,142
Total Liabilities & Equity
1,7641,8931,5821,4931,4481,265

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
-100---9.64
Net Cash (Debt)
764.99776.19639.05431.08799.76517.51
Net Cash Growth
4.63%21.46%48.24%-46.10%54.54%161.86%
Net Cash Per Share
8.448.597.124.828.956.12
Filing Date Shares Outstanding
90.0489.6889.1688.9388.9388.93
Total Common Shares Outstanding
90.0489.6889.1688.9388.9388.93
Working Capital
797.06772.36624.47488.19841.75667.49
Book Value Per Share
17.3617.1515.4215.3014.5712.84
Tangible Book Value
1,5631,5371,3751,3611,2941,140
Tangible Book Value Per Share
17.3617.1415.4215.3014.5612.82
Land
-133.23133.23133.23133.23133.23
Buildings
--310.48307.74303.11302.48
Machinery
-542.5181.24160.52149.88162
Construction In Progress
-13.0120.0817.6721.618.79
Leasehold Improvements
-13.4313.4318.9118.9123.7